FABP4 and type 2 diabetes mellitus: In addition, while previous studies have demonstrated that AFABP predicted MACE in patients with CAD [13], our study extended these findings by showing that high circulating AFABP level was also independently associated with MACE in T2DM patients even without CVD at baseline.